Article
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
Human gene therapy - 1 Oct 2018
Stock Sophia, Hoffmann Jean-Marc, Schubert Maria-Luisa, Wang Lei, Wang Sanmei, Gong Wenjie, Neuber Brigitte, Gern Ulrike, Schmitt Anita, Müller-Tidow Carsten, Dreger Peter, Schmitt Michael, Sellner Leopold
Abstract excerpt
Enhanced in vivo expansion, long-term persistence of chimeric antigen receptor T (CART) cells, and efficient tumor eradication through these cells are linked to the proportion of less-differentiated cells in the CART cell product. Retronectin is well established as an adjuvant for improved retroviral transduction, while its property to enrich less-differentiated T cells is less known. In order to increase these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
